BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26379189)

  • 1. BAC transgenic mice provide evidence that p53 expression is highly regulated in vivo.
    Chen L; Zhang GX; Zhou Y; Zhang CX; Xie YY; Xiang C; He XY; Zhang Q; Liu G
    Cell Death Dis; 2015 Sep; 6(9):e1878. PubMed ID: 26379189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.
    Gottlieb E; Haffner R; King A; Asher G; Gruss P; Lonai P; Oren M
    EMBO J; 1997 Mar; 16(6):1381-90. PubMed ID: 9135153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo.
    Komarova EA; Chernov MV; Franks R; Wang K; Armin G; Zelnick CR; Chin DM; Bacus SS; Stark GR; Gudkov AV
    EMBO J; 1997 Mar; 16(6):1391-400. PubMed ID: 9135154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cell death by lens-specific overexpression of bcl-2 in transgenic mice.
    Fromm L; Overbeek PA
    Dev Genet; 1997; 20(3):276-87. PubMed ID: 9216067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mouse model expressing P53(R172H), luciferase, EGFP, and KRAS(G12D) in a single open reading frame for live imaging of tumor.
    Ju HL; Calvisi DF; Moon H; Baek S; Ribback S; Dombrowski F; Cho KJ; Chung SI; Han KH; Ro SW
    Sci Rep; 2015 Jan; 5():8053. PubMed ID: 25623590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.
    Lohrum M; Scheidtmann KH
    Oncogene; 1996 Dec; 13(12):2527-39. PubMed ID: 9000127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling to p53: breaking the posttranslational modification code.
    Appella E; Anderson CW
    Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitosis-independent survivin gene expression in vivo and regulation by p53.
    Xia F; Altieri DC
    Cancer Res; 2006 Apr; 66(7):3392-5. PubMed ID: 16585159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 response to ionising radiation in adult and developing murine tissues.
    MacCallum DE; Hupp TR; Midgley CA; Stuart D; Campbell SJ; Harper A; Walsh FS; Wright EG; Balmain A; Lane DP; Hall PA
    Oncogene; 1996 Dec; 13(12):2575-87. PubMed ID: 9000131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
    Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
    Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
    Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW
    Cancer Res; 2002 Jul; 62(13):3667-74. PubMed ID: 12097273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target.
    Fierabracci A; Pellegrino M
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27897991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new transgenic mouse line to image chemically induced p53 activation in vivo.
    Briat A; Vassaux G
    Cancer Sci; 2008 Apr; 99(4):683-8. PubMed ID: 18377420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of p53 expression in the nervous system.
    Weisinger G; Tendler Y; Zinder O
    Brain Res Brain Res Protoc; 2000 Nov; 6(1-2):71-9. PubMed ID: 11086265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are p53 post-translational modifications required for its function in vivo?
    Cancer Biol Ther; 2005 Aug; 4(8):iii-iv. PubMed ID: 16710936
    [No Abstract]   [Full Text] [Related]  

  • 19. Using targeted transgenic reporter mice to study promoter-specific p53 transcriptional activity.
    Goh AM; Lim CY; Chiam PC; Li L; Mann MB; Mann KM; Menendez S; Lane DP
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1685-90. PubMed ID: 22307631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noninvasive iRFP713 p53 reporter reveals dynamic p53 activity in response to irradiation and liver regeneration in vivo.
    Humpton TJ; Hock AK; Kiourtis C; De Donatis M; Fercoq F; Nixon C; Bryson S; Strathdee D; Carlin LM; Bird TG; Blyth K; Vousden KH
    Sci Signal; 2022 Feb; 15(720):eabd9099. PubMed ID: 35133863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.